A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price increases after President Donald Trump rescinded a 2022 executive order on prescription drug prices has been shared online as authentic.

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest President Donald Trump has canceled the $35 insulin co-pay cap for certain Medicare programs.

AN EIGHT-year-old girl was left to die by her cult family who sang and prayed around her instead of providing lifesaving insulin. Fourteen of the religious fanatics, including her parents, have

The parents of Elizabeth Rose Struhs, who died in 2022, were part of a small religious sect in Australia that believed that medical care went against their faith.

After Natalie Cochran poisoned her husband, she told friends she would let him "sleep it off" instead of taking him to the hospital, prosecutors said.

President Donald Trump voided an executive order signed by former-President Joe Biden aimed at lowering prescription drug prices.

Researchers explore the impact of exercise on the short-term regulation of insulin pathways in brain circuits.

The final settlement has been reached in the state's 2018 lawsuit filed against the three largest insulin manufacturers.

Minnesota Attorney General Keith Ellison on Monday will share a major development in his lawsuit against three of the biggest insulin manufacturers. Ellison first accused the companies of deceptive pricing back in 2018. Now, Minnesotans are paying less for insulin — depending on where they’re buying it from.

Elizabeth Struhs, eight, died of diabetic ketoacidosis in 2022 at her family home in Queensland after her parents and other members of a cult-like religious group withdrew her life-saving medication.

Prices for insulin, the essential drug for treating diabetes, have plummetted to their lowest levels in a decade following a rise in generic options. In